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Effects of an Anabolic Implant and Transport on Metabolic Status and 
Muscle Traits of Feedlot Steers 
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Summary 
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A study was conducted to determine the effects 
of implants and transportation on the metabolic 
status of feedlot steers.  Steers (n = 28) were 
sorted by body weight, allocated into light or 
heavy blocks, and randomly assigned to one of 
two treatments.  Treatments included non-
implanted controls (CON) and steers implanted 
with Synovex Plus 70 d prior to harvest (IMP).  
Jugular blood and muscle biopsy samples 
(longissimus dorsi (LD) and semimembranosis 
(SM)) were collected 70 d post-implant, prior to 
transit.  Steers were transported to Schuyler, 
NE, where blood and biopsy sampling was 
repeated.  After harvest, carcass data were 
collected and muscle samples were taken from 
the LD, SM, Psoas Major (PM), and Illiacus (IL) 
muscles.  Implanting increased (P < 0.05) 
estradiol levels and improved live animal 
performance.  Carcass weight and rib eye area 
were increased (P < 0.05) in implanted steers.  
No dark cutters were found in either treatment.  
Pre-transit insulin/glucagon ratio and muscle 
glycogen levels did not differ (P > 0.10) between 
treatments.  Non-esterified fatty acid (NEFA) 
levels were reduced (P < 0.05) in implanted 
steers pre-transit.  Transit increased (P < 0.05) 
NEFA levels, but had no effect (P > 0.10) on 
insulin/glucagon ratio or muscle glycogen levels.  
Implanting did not affect (P > 0.10) 
insulin/glucagon ratio, NEFA, or LD glycogen 
levels post-transit.  Implanted steers had lower 
(P < 0.05) glycogen levels in the SM than did 
non-implanted steers post-transit.  Weight block 
affected (P < 0.05) insulin and insulin/glucagon 
ratio levels, with steers in the light block having 
greater levels of each.  Muscle pH and objective 
color (L*, a*, b*) of the LD were not biologically 
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different between treatments.  Implanted steers 
had greater (P < 0.05) glycolytic potential values 
in the LD, and tended (P < 0.10) to have higher 
L* values in the PM.  Implanting increased (P < 
0.05) shear force of the LD.  These data indicate 
that although implants affect bovine metabolism, 
other factors are necessary to cause a sufficient 
reduction in muscle glycogen and to produce a 
dark cutting carcass. 
 
Introduction 
 
Dry, firm, and dark beef (dark cutters) is thought 
to be caused by a lack of muscle glycogen prior 
to harvest.  Glycogen is the storage form of 
glucose in hepatic and muscular tissues, and is 
used by an animal to generate energy.  When 
an animal is harvested, glycogen is utilized 
anaerobically in muscular tissue.  Muscle 
glycogen consumption postmortem generates 
lactic acid, which lowers muscle pH from 
approximately 7.2 pre-harvest to 5.4 at 24 h 
post-harvest.  Low levels of glycogen in 
muscular tissue postmortem can lead to the dark 
cutting condition if pH reduction is severely 
limited.  If muscle pH is unusually high, i.e. 
above 5.8, the cut surface is at risk to become 
dryer and darker in color.   
 
Pre-harvest stressors are thought to reduce 
muscle glycogen levels and cause the dark 
cutting condition.  These include psychological, 
physiological, and genetic factors.  The use of 
implants as a physiological factor may play a 
role in the dark cutting condition, but definitive 
cause and effect relationships have not been 
established. 
 
Metabolic factors that play a role in glycogen 
metabolism include blood levels of insulin and 
glucagon in the animal.  Insulin is an inducer of 
enzymes that promote glucose uptake into 
muscle tissue and is released when blood 
glucose levels are elevated.  Glucagon 
promotes the release of glucose from hepatic 
tissue into systemic blood circulation, and is 
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usually released when circulating glucose levels 
are low.  It is believed the insulin/glucagon ratio 
determines the metabolic state of an animal 
rather than the absolute levels of either 
hormone.  Besides glucose, other compounds, 
namely non-esterified fatty acids (NEFA) and 
amino acids, can be used by the animal for 
energy.  Increased circulating NEFA levels 
indicate the animal is mobilizing triglyceride 
stores and may be using fatty acids for energy 
substrate.   
 
The objective of this study was to determine the 
effect of implants on muscle glycogen status and 
consequently dark cutting in finishing steers.  
Additionally, this study intended to examine the 
effect of transportation on muscle glycogen and 
blood parameters in finishing steers. 
 
Materials and Methods 
 
Steers (n = 28) of predominantly Angus 
background were sorted by body weight and 
blocked into light and heavy weight groups.  
They were then randomly assigned to one of two 
treatments, and one of two pens within each 
treatment.  Steers were fed a typical finishing 
diet (Table 1) twice daily for the duration of the 
study.  Bunk scores and pen intake were 
recorded daily prior to morning feeding. 
Steers that did not receive an implant (CON) 
were designated as control animals.  Implanted 
steers (IMP) were given Synovex Plus 70 d prior 
to harvest.  Implants were checked at 21 d, with 
none found to be defective or missing.  Live 
weights were taken prior to morning feeding at 
1, 21, 42, and 70 d.   
At 70 d, blood and muscle biopsy samples were 
taken on the left side of each animal prior to 
morning feeding.  Blood was collected via 
jugular venipuncture into vacuum-sealed tubes 
to yield plasma and serum samples.  Plasma 
was obtained after blood collection by 
centrifugation at 3000 x g for 30 min and stored 
at -20oC until further analysis.  Serum was 
obtained over 24 h after initial blood collection 
by centrifugation at 3000 x g for 30 min and was 
also stored at -20oC until further analysis.  A 
single biopsy sample of approximately 50 mg 
was taken from the Longissimus dorsi (LD) and 
Semimembranosis (SM) of each steer using the 
Bergstrom needle technique.  Samples were 
collected from the LD approximately 12 in dorsal 
to the hook bone.  Samples collected from the 
SM were taken from the left side of the animal at 
approximately the midpoint of the muscle. 
On the afternoon of sampling, steers were 
transported 261 mi to Schuyler, NE, for harvest.  
Prior to harvest, steers were unloaded near (< 4 
mi) the packing plant where jugular blood and 
muscle biopsy collections were repeated.  
Steers were then transported to the packing 
plant and harvested the following morning. 
 
Carcasses were chilled for 120 h prior to 
grading.  Three carcasses were lost in the 
packing plant prior to data collection.  All 
variables needed to determine carcass USDA 
Quality and Yield Grades were recorded by 
trained SDSU personnel.  The presence of the 
dark cutting condition was determined by USDA 
grading personnel.  Postmortem carcass pH and 
objective color (L*, a*, b*) measurements were 
collected at 5 d postmortem by plant personnel.  
Carcass pH was measured using a pH-Star 
probe (SFK Tech., Herelev, Denmark) that was 
inserted into the LD of each carcass.  Objective 
color was taken on the cut surface of the LD 
using a Minolta CR-300 colorimeter (Minolta 
Corp., Ramsey, NJ).  Samples of four muscles, 
the LD, SM, Psoas Major (PM), and Illiacus (IL) 
were obtained and returned to the university 
abattoir for determination of individual muscle 
pH, objective color, shear force, and glycolytic 
potential at 7 d postmortem.  Muscle pH and 
glycolytic potential were determined on all four 
muscles.  Objective color was determined on the 
LD, PM, and IL.  Shear force was determined on 
the LD.      
Muscle tissue (10 g; 7 d postmortem) was 
homogenized in 90 mL of deionized water using 
a Ultra-Turrax T25 homogenizer and S25N 
probe (Divitech Equipment Co., Cincinnati, OH).  
Muscle pH was then determined on the 
homogenate using an Orion 420A pH meter 
(Boston, MA).  To eliminate the possibility of 
bacterial contamination, all muscle pH samples 
were analyzed within 48 h of collection from the 
packing plant.  Objective color was determined 
on individual muscle samples using a Minolta 
CR-310 colorimeter (Minolta Corp., Ramsey, 
NJ).  Samples were allowed to bloom a 
minimum of 40 min prior to objective color 
determination.  Shear force was determined 
through the Warner-Bratzler method.   
Glycolytic potential was determined through two 
separate assays.  Residual glycogen in muscle 
tissue post-harvest and muscle lactate (salt form 
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of lactic acid) were determined through 
enzymatic analysis.  Based on the values of 
these assays, the equation [(2 x glycogen) + 
lactate] was then used to determine the 
glycolytic potential of each muscle examined.   
Plasma samples were used to determine 
circulating estradiol and glucagon 
concentrations in steers.  Serum samples were 
used to determine insulin and NEFA 
concentrations.  Estradiol, insulin, and glucagon 
were determined through radioimmunoassay 
analysis.  Non-esterified fatty acid levels were 
determined through colorimetric analysis.  
Glycogen concentration was determined in 
biopsy samples by enzymatic analysis. 
Production data were determined based on a 
4% shrink applied to body weight values with 
pen being considered the experimental unit.  All 
other data were analyzed with steer as the 
experimental unit.  With the exception of 
performance data, all models used to analyze 
data contained weight block as a factor.  
Transportation was included in the model as a 
main effect in samples collected both pre- and 
post-transport.  All data were analyzed using the 
GLM procedure of SAS.  Chi-square analysis 
was conducted on shear force data.  
 
Results and Discussion 
 
Implants increased production rates and serum 
estradiol of steers (Table 2) confirming their 
biological activity.  Hot carcass weight (HCW) 
and rib eye area were increased (P < 0.05) due 
to implants (Table 3).  No carcasses in either 
treatment were classified as dark cutting.   
 
There was a tendency (P = 0.087) for a 
treatment x group x transit interaction with 
insulin levels (Table 4).  Transit tended to 
decrease (P = 0.069) insulin levels of implanted, 
light steers.  No differences (P > 0.10), with 
respect to implant treatment and transit, were 
found on insulin levels in non-implanted steers 
and heavy implanted steers.  Insulin levels 
varied greatly (P < 0.01) between weight block, 
with lighter steers having an insulin level of 555 
pg/ml versus heavy steers having an insulin 
level of 332 pg/ml.  There was also a tendency 
(P = 0.057) for glucagon levels to be lower in 
heavier cattle (109 pg/ml light group versus 91 
pg/ml heavy group).  Lighter steers had higher 
(P < 0.05) insulin/glucagon ratio values than 
heavier steers (5.48 light group versus 3.59 
heavy group).  It appeared weight block played a 
larger role in influencing the insulin/glucagon 
ratio in this experiment than did either implant 
treatment or transportation. 
 
The NEFA levels were lower (P < 0.05) in 
implanted steers prior to transit (Table 5).  
Transit increased (P < 0.05) NEFA levels in 
each implant treatment.  There were no post-
transit differences (P > 0.10) in NEFA due to 
implants.  Implants had no effect  
(P > 0.10) on glycogen levels in the LD and SM 
pre-transit.  Transportation had no effect (P > 
0.10) on glycogen levels in the LD and SM.  
Post-transit, implanted steers had lower (P < 
0.05) glycogen values in the SM than did non-
implanted steers.  The LD had higher (P < 0.01) 
glycogen levels than the SM (104 µmol/g LD 
versus 83 µmol/g SM) in both implant 
treatments.   
 
Longissimus dorsi muscle pH, determined 5 d 
postmortem, was lower (P < 0.05) in implanted 
steers (Table 6).  It is of interest to note that the 
statistical difference in pH demonstrated here 
would indicate implanted steers are less likely to 
become dark cutters versus non-implanted 
steers.  However, this difference is of little 
biological relevance as both treatments had 
carcass pH values well below 5.8.  Muscle pH, 
determined 7 d postmortem, did not differ (P > 
0.10) between treatments for the SM, PM, or IL 
muscles.  There was a tendency (P = 0.098) for 
implanted steers to have higher postmortem L* 
values in the PM (43.34 CO versus 44.24 IMP) 7 
d postmortem.  However, a* and b* values were 
not different (P > 0.10) between treatments for 
the PM.  Objective color values did not differ (P 
> 0.10) between treatments for the LD or IL 
muscles.   
 
Implants increased (P < 0.05) shear force values 
of the LD (Table 6).  Implanted steers had a 
tendency (P = 0.087) to produce lower 
percentage tender (shear force < 3.5 kg) and 
higher percentage tough (shear force > 5.0 kg) 
steaks versus non-implanted steers.  
 
The LD from implanted steers had greater (P < 
0.05) glycolytic potential values than non-
implanted steers (Table 7).  Their was a 
tendency (P = 0.074) for implanted steers to 
have lower glycolytic potential levels than non-
implanted steers in the PM.  The decrease in 
glycolytic potential is mainly due to a tendency 
for decreased (P = 0.097) glycogen levels in the 
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PM of implanted steers after carcass fabrication.  
Implants had no effect (P > 0.1) on the 
proportion of lactate produced as a percentage 
of the total glycolytic potential.  The IL and PM 
were similar (P > 0.10) in lactate produced, and 
produced more (P < 0.01) lactate as a ratio of 
the total glycolytic potential than the LD and SM 
muscles (81.3 % IL, 78.4 % PM, 66.7 % LD, and 
52.7 % SM, respectively).  In addition the LD 
had a greater (P < 0.01) percentage of lactate 
produced than the SM. 
 
Conclusions 
 
Implants had a desirable effect on steer 
performance.  In this study, implanted steers 
produced no dark cutting carcasses, and muscle 
glycogen levels in the Longissimus dorsi were 
unaffected by implants.  Glycolytic potential 
values were increased in implanted steers.  
Muscle pH and objective color values did not 
exhibit biologically relevant differences between 
implanted and non-implanted animals.  Some 
metabolic changes occurred, as implanted cattle 
had reduced NEFA levels and yielded steaks 
that were tougher on average.  Although 
implanted cattle did show altered NEFA levels, 
transit had a much greater effect on this factor.  
Insulin/Glucagon ratio was not affected by 
implants, but was related to body weight. 
  
 
 
 
 
 
 
Tables 
 
 
 
Table 1.  Finishing trial dieta
Ingredient % 
Whole Shell Corn 55.00 
High Moisture Corn 19.75 
Corn Silage 13.00 
Liquid Supplementb 4.25 
  
CPc 11.50 
NEm, Mcal/cwtd 91.35 
NEg, Mcal/cwtd 60.75 
aDM basis. 
bProvided monensin and tylosin to make final diet 28 g/T and 11 g/T, respectively; 
provided vitamins and minerals to meet or exceed nutrient requirements (NRC, 1996). 
cBased on weekly sample analysis. 
dDerived from tabular values for feeds used (NRC, 1996). 
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Table 2.  Interim period and cumulative performance of steers by treatmenta
  Control Implanted SEM 
Initial BW, lbb 949 945 10.5 
1 to 21 d    
 BW, lbb 1027 1037 8.5 
 ADG, lb 3.85 4.57 0.23 
 DMI, lb 21.44 21.9 0.43 
 F/G 5.59 4.81 0.32 
21 to 42 d    
 BW, lbb 1087 1109 10.4 
 ADG, lb 3.00 3.62 0.21 
 DMI, lb 23.07 23.83 0.46 
 F/G 7.72 6.61 0.33 
42 to 70 d    
 BW, lbb 1162 1203 12.0 
 ADG, lb 2.82c 3.45d 0.11 
 DMI, lb 22.39 23.03 0.70 
 F/G 7.98 6.68 0.36 
1 to 70 d    
 ADG, lb 3.18e 3.83f 0.05 
 DMI, lb 22.31 22.93 0.45 
 F/G 7.02c 5.99d 0.18 
Estradiol, pg/ml 19e 9f 1.1 
aLeast squares means. 
bAdjusted with 4% shrink. 
cdMeans with uncommon superscripts differ (P < 0.10). 
ef Means with uncommon superscripts differ (P < 0.05). 
 
 
 
 
Table 3.  Carcass characteristics by treatmenta
  Control Implanted SEM 
HCW, lb 738d 766e 6.96 
Dress %b 62.15 62.18 0.004 
Rib fat, in 0.43 0.44 0.03 
Rib eye area, in2 11.78d 12.18e 0.14 
KPH, % 1.94 1.86 0.11 
Marblingc 5.44 5.15 0.15 
Yield Grade 3.04 3.03 0.08 
aLeast squares means. 
bAdjusted with 4% shrink. 
c5.0=small0; 4.0=slight0. 
deMeans with uncommon superscripts differ (P < 0.05). 
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Table 4. Insulin, glucagon, and insulin/glucagon ratio by treatment and weight blockab
  CON Light CON Heavy IMP Light IMP Heavy SEM 
Pre-Transit      
 Insulin, pg/mlc 475de 355d 665e† 287d 67.37 
 Glucagon, pg/ml 108fg 104fg 115f 81g 8.34 
 Insulin/Glucagon 4.76 3.59 6.46 3.59 0.88 
      
Post Transit      
 Insulin, pg/mlc 631d 324e 450de† 284e 63.08 
 Glucagon, pg/ml 107 88 105 90 9.49 
 Insulin/Glucagon 6.31f 3.96g 4.37g 3.22g 0.65 
aLeast squares means. 
bLight and heavy denote weight block 
cImplant treatment * transportation * weight block interaction (P = 0.087). 
deMeans with uncommon superscripts differ (P < 0.05). 
fgMeans with uncommon superscripts differ (P < 0.10). 
†Corresponding values within a column differ (P < 0.10). 
 
 
Table 5.  Live animal muscle glycogen and NEFA by treatmenta
  Control Implanted SEM 
Pre-transit    
 NEFA, meq/l 0.156c* 0.116d* 0.01 
 Longissimus Glycogen, µmol/gb 111 104 11.7 
 Semimembranosis Glycogen, µmol/gb 86 79 5.4 
    
Post-transit    
 NEFA, meq/l 0.228* 0.212* 0.02 
 Longissimus Glycogen, µmol/gb 97 103 11.5 
 Semimembranosis Glycogen, µmol/gb 97c 68d 9.7 
aLeast squares means. 
bFresh wt. basis, obtained from live animal. 
cdMeans with uncommon superscripts differ (P < 0.05). 
*Corresponding values within a column differ (P < 0.05). 
 
 
Table 6.  Carcass pH, objective color (L*, a*, b*) and shear force of the longissimus dorsi by treatment 
 Controla Implanteda SEM 
    
pHb 5.48g 5.43h 0.01 
L*bc 36.88 37.09 0.45 
a*bd 24.38 24.05 0.45 
b*be 11.13 10.83 0.19 
Shear force, kg 3.58g 4.42h 0.21 
Shear force distributionf
 Shear < 3.5 kg, % 46.15 9.09  
 Shear >3.5, < 5.0 kg, % 53.85 72.73  
 Shear > 5.0 kg, % 0 18.18  
aLeast squares means. 
bDetermined at time of grading. 
c0=black, 100=white. 
dNegative values = green, positive values = red. 
eNegative values = blue, positive values = yellow. 
fChi-Square probability = 0.06. 
ghMeans with uncommon superscripts differ (P < 0.05). 
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Table 7.  Muscle residual glycogen and lactate concentrationsa
 CO IMP SEM 
Longissimus dorsi    
 Glycogen, µmol/g 21 25 1.80 
 Lactate, µmol/g 87 91 1.30 
 Glycolytic potential, µmol/gb 128d 141e 3.99 
 Lactate, %c 68.4 65.0 1.71 
    
Semimembranosis    
 Glycogen, µmol/g 44 45 2.49 
 Lactate, µmol/g 97 99 1.78 
 Glycolytic potential, µmol/gb 186 189 5.56 
 Lactatec 52.8 52.7 1.42 
    
Psoas major    
 Glycogen, µmol/g 13f 10g 1.18 
 Lactate, µmol/g 81 79 1.33 
 Glycolytic potential, µmol/gb 106f 98g 3.04 
 Lactatec 76.4 80.5 1.79 
    
Illiacus    
 Glycogen, µmol/g 9 8 1.25 
 Lactate, µmol/g 69 72 1.37 
 Glycolytic potential, µmol/gb 87 88 2.54 
 Lactatec 79.9 82.7 2.31 
aLeast squares means 
bCalculated by the equation (2 X glycogen) + lactate. 
c µmol*g-1 lactate / µmol*g-1 glycolytic potential x 100. 
deMeans with uncommon superscripts differ (P < 0.05). 
fgMeans with uncommon superscripts differ (P < 0.1). 
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